LY2452473
Names
Biological Activity
[Description]:
LY2452473 is an orally bioavailable, selective androgen receptor modulator (SARM).
[Related Catalog]:
[Target]
Androgen receptor[1]
[In Vivo]
LY2452473 is a selective androgen receptor modulator being developed for the treatment of disorders related to hypogonadism. LY2452473 is absorbed rapidly (time to reach maximum plasma concentration for both LY2452473 and total radioactivity is 2-3 h) and cleared slowly (plasma terminal t1/2 of 27 h for LY2452473 and 51 h for the total radioactivity)[1].
[References]
[Related Small Molecules]
ARN-509
|
Dehydroepiandrosterone
|
Flutamide
|
ODM-201
|
Danazol
|
3,3'-Diindolylmethane
|
AZD3514
|
RAD140
|
BMS-564929
|
GLPG0492
|
Cyproterone acetate
|
LGD-4033
|
Lupeol
|
Andarine
|
MK-0773
Chemical & Physical Properties
[ Molecular Formula ]:
C22H22N4O2
[ Molecular Weight ]:
374.43600
[ Exact Mass ]:
374.17400
[ PSA ]:
83.43000
[ LogP ]:
3.76248
[ Storage condition ]:
2-8℃
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.